title: Regulable Transgene Expression in Dorsal Root Ganglia of a Replication-Defective Herpes Simplex Virus Type 1 Vector by Means of Sciatic Nerve Injection.
abstract: BACKGROUND
  Targeted and controllable gene delivery to neurons is essential to efforts to facilitate peripheral nerve regeneration. The authors investigated both the in vitro and in vivo expression profiles of a tetracycline-controlled, replication-defective, herpes simplex virus type 1-based vector.
  
  
  METHODS
  Mouse primary dorsal root ganglia cells were infected with QR9TO-LacZ in the absence or presence of tetracycline. LacZ gene expression was examined. It was also injected into sciatic nerves in CD-1 mice fed with and without tetracycline. LacZ expression in the upstream dorsal root ganglia was examined.
  
  
  RESULTS
  Following inoculation with QR9TO-LacZ, approximately 40 percent of the cultured primary dorsal root ganglia cells exhibited strong LacZ activity in the presence of tetracycline at 48 and 72 hours, whereas little was detected in those in the absence of tetracycline. Quantitative analysis revealed that the β-galactosidase activity within cells exposed to tetracycline increased 181-fold at 48 hours (p < 0.001) and 47-fold at 72 hours after infection (p < 0.05) compared with those without tetracycline. However, this LacZ transgene activity in the presence of tetracycline tapered off to less than sevenfold over baseline 168 hours after infection (p < 0.05). Furthermore, successful uptake of this replication-defective viral vector was evident in upstream dorsal root ganglia after sciatic nerve injection in mice. In addition, its expression profile was similar to that in vitro, as strong β-galactosidase activity was evident only in mice fed with a doxycycline-containing diet, and it tapered off by 168 hours.
  
  
  CONCLUSIONS
  The replication-defective herpes simplex virus type 1-based vector, which provides tightly regulated transgene expression in dorsal root ganglia by means of peripheral nerve injection, represents an appealing approach to improve peripheral nerve regeneration.
authors.affiliation: Burlington and Boston, Mass. From the Department of Plastic Surgery, Lahey Hospital & Medical Center; the Department of Surgery, Brigham and Women's Hospital.
authors.forename: Bin
authors.initials: B
authors.lastname: Chen
authors.forename: Feng
authors.initials: F
authors.lastname: Yao
authors.forename: Lifei
authors.initials: L
authors.lastname: Guo
mesh_terms: D000818:Animals; D005260:Female; D005727:Ganglia, Spinal / Q000821:virology*; D015967:Gene Expression Regulation, Viral / Q000187:drug effects; D018014:Gene Transfer Techniques; D018259:Herpesvirus 1, Human / Q000235:genetics* / Q000502:physiology; D007267:Injections; D007763:Lac Operon / Q000235:genetics*; D051379:Mice; D012584:Sciatic Nerve; D013752:Tetracycline / Q000494:pharmacology; D019076:Transgenes / Q000235:genetics*; D014779:Virus Replication / Q000235:genetics
chemical_list: D013752:Tetracycline
references.citation: Yegiyants S, Dayicioglu D, Kardashian G, Panthaki ZJ. Traumatic peripheral nerve injury: A wartime review. J Craniofac Surg. 2010;21:998–1001
references.citation: Eser F, Aktekin LA, Bodur H, Atan C. Etiological factors of traumatic peripheral nerve injuries. Neurol India. 2009;57:434–437
references.citation: Taylor CA, Braza D, Rice JB, Dillingham T. The incidence of peripheral nerve injury in extremity trauma. Am J Phys Med Rehabil. 2008;87:381–385
references.citation: Ciaramitaro P, Mondelli M, Logullo F, et al. Traumatic peripheral nerve injuries: Epidemiological findings, neuropathic pain and quality of life in 158 patients. J Peripher Nerv Syst. 2010;15:120–127
references.citation: Yildiz M, Karlidag T, Yalcin S, et al. Efficacy of glial growth factor and nerve growth factor on the recovery of traumatic facial paralysis. Eur Arch Otorhinolaryngol. 2011;268:1127–1133
references.citation: Khuong HT, Kumar R, Senjaya F, et al. Skin derived precursor Schwann cells improve behavioral recovery for acute and delayed nerve repair. Exp Neurol. 2014;254:168–179
references.citation: Matsumine H, Takeuchi Y, Sasaki R, et al. Adipocyte-derived and dedifferentiated fat cells promoting facial nerve regeneration in a rat model. Plast Reconstr Surg. 2014;134:686–697
references.citation: Rochkind S, Nevo Z. Recovery of peripheral nerve with massive loss defect by tissue engineered guiding regenerative gel. Biomed Res Int. 2014;2014:327578
references.citation: Tannemaat MR, Verhaagen J, Malessy M. The application of viral vectors to enhance regeneration after peripheral nerve repair. Neurol Res. 2008;30:1039–1046
references.citation: Zacchigna S, Giacca M. Chapter 20: Gene therapy perspectives for nerve repair. Int Rev Neurobiol. 2009;87:381–392
references.citation: Esaki S, Kitoh J, Katsumi S, et al. Hepatocyte growth factor incorporated into herpes simplex virus vector accelerates facial nerve regeneration after crush injury. Gene Ther. 2011;18:1063–1069
references.citation: Hoyng SA, Tannemaat MR, De Winter F, Verhaagen J, Malessy MJ. Nerve surgery and gene therapy: A neurobiological and clinical perspective. J Hand Surg Eur Vol. 2011;36:735–746
references.citation: Shakhbazau A, Kawasoe J, Hoyng SA, et al. Early regenerative effects of NGF-transduced Schwann cells in peripheral nerve repair. Mol Cell Neurosci. 2012;50:103–112
references.citation: Stieger K, Belbellaa B, Le Guiner C, Moullier P, Rolling F. In vivo gene regulation using tetracycline-regulatable systems. Adv Drug Deliv Rev. 2009;61:527–541
references.citation: Bowers WJ, Breakefield XO, Sena-Esteves M. Genetic therapy for the nervous system. Hum Mol Genet. 2011;20:R28–R41
references.citation: Verhaagen J, Hermens WT, Dijkhuizen PA, Holtmaat AJ, Gispen WH. Use of viral vectors to promote neuroregeneration. Clin Neurosci. 1995;3:275–283
references.citation: Drescher KM, Tracy SM. Injection of the sciatic nerve with TMEV: A new model for peripheral nerve demyelination. Virology. 2007;359:233–242
references.citation: Manservigi R, Argnani R, Marconi P. HSV recombinant vectors for gene therapy. Open Virol J. 2010;4:123–156
references.citation: Wolfe D, Mata M, Fink DJ. A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther. 2009;16:455–460
references.citation: Yao F, Theopold C, Hoeller D, Bleiziffer O, Lu Z. Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector. Mol Ther. 2006;13:1133–1141
references.citation: Palmer JA, Branston RH, Lilley CE, et al. Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system. J Virol. 2000;74:5604–5618
references.citation: Antunes Bras JM, Epstein AL, Bourgoin S, Hamon M, Cesselin F, Pohl M. Herpes simplex virus 1-mediated transfer of preproenkephalin A in rat dorsal root ganglia. J Neurochem. 1998;70:1299–1303
references.citation: Shakhbazau A, Mohanty C, Shcharbin D, et al. Doxycycline-regulated GDNF expression promotes axonal regeneration and functional recovery in transected peripheral nerve. J Control Release. 2013;172:841–851
references.citation: Puttini S, van Zwieten RW, Saugy D, et al. MAR-mediated integration of plasmid vectors for in vivo gene transfer and regulation. BMC Mol Biol. 2013;14:26
references.citation: Imhof MO, Chatellard P, Mermod N. Comparative study and identification of potent eukaryotic transcriptional repressors in gene switch systems. J Biotechnol. 2002;97:275–285
references.citation: Homs J, Ariza L, Pages G, et al. Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration. Gene Ther. 2011;18:622–630
references.citation: Kells AP, Eberling J, Su X, et al. Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF. J Neurosci. 2010;30:9567–9577
references.citation: Blesch A, Conner JM, Tuszynski MH. Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression. Gene Ther. 2001;8:954–960
references.citation: Fink DJ, DeLuca NA, Yamada M, Wolfe DP, Glorioso JC. Design and application of HSV vectors for neuroprotection. Gene Ther. 2000;7:115–119
references.citation: Fink DJ, Wechuck J, Mata M, et al. Gene therapy for pain: Results of a phase I clinical trial. Ann Neurol. 2011;70:207–212
references.citation: Krisky DM, Wolfe D, Goins WF, et al. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 1998;5:1593–1603
references.citation: Yao F, Svensjö T, Winkler T, Lu M, Eriksson C, Eriksson E. Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther. 1998;9:1939–1950
references.citation: Stieger K, Mendes-Madeira A, Meur GL, et al. Oral administration of doxycycline allows tight control of transgene expression: A key step towards gene therapy of retinal diseases. Gene Ther. 2007;14:1668–1673
references.citation: Stieger K, Le Meur G, Lasne F, et al. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Mol Ther. 2006;13:967–975
references.citation: Everett RD. HSV-1 biology and life cycle. Methods Mol Biol. 2014;1144:1–17
references.citation: Frampton AR Jr, Goins WF, Nakano K, Burton EA, Glorioso JC. HSV trafficking and development of gene therapy vectors with applications in the nervous system. Gene Ther. 2005;12:891–901
references.citation: Glorioso JC, Mata M, Fink DJ. Exploiting the neurotherapeutic potential of peptides: Targeted delivery using HSV vectors. Expert Opin Biol Ther. 2003;3:1233–1239
references.citation: Ren B, O’Brien BA, Swan MA, et al. Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy. Diabetologia. 2007;50:1910–1920
references.citation: Puskovic V, Wolfe D, Goss J, et al. Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo. Mol Ther. 2004;10:67–75
references.citation: Chattopadhyay M, Mata M, Goss J, et al. Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer. Diabetologia. 2007;50:1550–1558